FLT4 and neoplasm: We eventually explored VEGFR-3 expression in cancer types of endothelial origin, such as Kaposi sarcoma, and could confirm that VEGFR-3 was highly expressed in tumor cells and the TME (Fig. 2F) as reported previously (37).